A149 SAFETY AND EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGOGASTRIC NEOPLASMS IN A CANADIAN SETTING
A AlDarwish, R Bechara

TL;DR
This study shows that endoscopic submucosal dissection is a safe and effective treatment for early esophagogastric tumors in Canada.
Contribution
The paper provides the first detailed Canadian data on ESD outcomes for superficial gastrointestinal neoplasms.
Findings
ESD achieved high technical success (98%) and curative resection rates (80%) for esophagogastric neoplasms.
Adverse events occurred in only 8% of cases, indicating good safety profile.
42% of lesions were upstaged from initial biopsy, highlighting the diagnostic value of ESD.
Abstract
Endoscopic submucosal dissection (ESD) is a technique that has been developed in Japan and is increasingly being adopted by western countries for treatment of superficial gastrointestinal neoplasms. In this study, we aim to present the safety and efficacy of ESD for esophageal and gastric neoplasms in a Canadian setting, given the limited data regarding the outcomes of ESD in North America Data of 100 patients with superficial upper GI neoplasms (esophageal and gastric) who underwent ESD between 2016 and 2022 in Kingston Health Sciences Centre, a tertiary hospital in Kingston, Ontario, were retrospectively reviewed. Demographics and lesion characteristics, ESD technique, and outcomes in terms of efficacy and safety were analyzed. 100 patients were included in the study. 67% of the lesions were esophageal. The median diameter was 4.6cm and median area was 11.94cm2. Outcomes were…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGastric Cancer Management and Outcomes · Esophageal Cancer Research and Treatment · Metastasis and carcinoma case studies
